Consolidated Statements of Changes in Shareholders' Deficit (Parenthetical) - USD ($) $ in Millions		3 Months Ended	9 Months Ended
		Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Common stock (in dollars per share)		$ 0.01	$ 0.01	$ 0.01
Common stock, shares outstanding (in shares)		101.34	101.34	101.34
Net proceeds from sale of business / assets			$ 0.0	$ 13.9
Gain on sale of business	[1]	$ 148.4

[1] On July 1, 2021, the Company sold Avon Luxembourg and its subsidiaries, including our Mexican business, to a subsidiary of Natura &Co Holding S.A. for $150. The sale was accounted for as a transaction under common control in accordance with ASC805 - Business Combinations, with the resulting gain of $148, representing the difference between the proceeds, the net assets of Avon Luxembourg on the date of sale, and the cumulative foreign currency translation adjustment, taken directly to Retained Earnings.